Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

L-Carnitine and Increased Hemoglobin Levels

Doses used in studies

mg/week: 7,200 (median 7,200, IQR 7,200–7,200) — 1 study

Time to effect

Median: 12.2 months · IQR 12.2 months–12.2 months · Range 12.2 months–12.2 months — Reported in 1 of 2 studies

2 of 2 papers

Effect of L-carnitine supplementation on renal anemia in patients on hemodialysis: a meta-analysis.
- 2021-03-13
- Meta-Analysis · n = 1,090
- International urology and nephrology 53(10)
- - Yan Zhu
  - Chao Xue
  - Jihong Ou
  - Zhijuan Xie
  - Jin Deng
- PubMed: 33713287
- DOI: 10.1007/s11255-021-02835-5
4 Insights on
- Increased Hemoglobin Levels
- High evidence
- Clinical
the use of L-carnitine was not associated with a higher hematocrit level (MD: 1.07, 95% CI -0.73 to 2.87; P = 0.24)
Effect
Neutral
Effect size
Small
Significant
No
Effects of L-Carnitine Supplementation in Patients Receiving Hemodialysis or Peritoneal Dialysis.
- 2020-11-01
- Clinical Trial
- Nutrients 12(11)
- - Masako Kuwasawa-Iwasaki
  - Hiroaki Io
  - Masahiro Muto
  - Saki Ichikawa
  - Keiichi Wakabayashi
  - Reo Kanda
  - Junichiro Nakata
  - Nao Nohara
  - Yasuhiko Tomino
  - Yusuke Suzuki
- PubMed: 33139659
- DOI: 10.3390/nu12113371
2 Insights on
- Increased Hemoglobin Levels
- High evidence
- Rigorous Journal
- Clinical
Hemoglobin concentrations increased significantly at 12 and 24 months in the HD group.
Effect
Beneficial
Effect size
Small
Significant
Yes
Dose
600 mg/day oral for 12 months and 1000 mg intravenous three times/week for 12 months